Sharing some alpha from an update @BioProtocol sent to all strategic $BIO investors yesterday: Beyond the strong $AUBRAI performance so far, it’s exciting to see how much is being worked on, and what’s already in the pipeline: TLDR: More scientists joining = more hypotheses = more innovation = more IP being materialized. All accelerated by @Aubrai_ & @aubreydegrey. On top of that, I’ve had multiple conversations with @paulkhls and the whole Bio team directly, and I’m increasingly confident that Aubrai (and BioAgents overall) might be one of the most solid applications of agents in crypto I’ve seen to date. This isn’t just another “agent launchpad” built to churn out quick pump & dumps. The team is laser-focused on making Aubrai a fundamentally strong and sustainable success. In turn, that will attract even more top-tier scientists to launch their own BioAgents, making upcoming launches even more fascinating and successful. The beautiful positive feedback loop you get when...
32.28K
295
The content on this page is provided by third parties. Unless otherwise stated, OKX TR is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX TR. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX TR is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.